TAVI in nonagenarians, what do we know so far?
Transcatheter aortic valve implantation (TAVI) has become a widely used therapeutic strategy to treat symptomatic severe aortic stenosis. Certain randomized clinical trials available have already described the prognostic benefit of this technique in elderly patients with high or very high surgical r...
Enregistré dans:
Auteurs principaux: | Pablo Díez-Villanueva, Fernando Rivero |
---|---|
Format: | article |
Langue: | EN ES |
Publié: |
Permanyer
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/5c6f1b4ee0ba499fb09a81b330496ece |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Vitamin E and Alzheimer’s disease: what do we know so far?
par: Browne D, et autres
Publié: (2019) -
Spaceflight-induced neuroplasticity in humans as measured by MRI: what do we know so far?
par: Angelique Van Ombergen, et autres
Publié: (2017) -
Heart Rate Variability and Cardiovascular Fitness: What We Know so Far
par: Souza HCD, et autres
Publié: (2021) -
Identifying High-Risk NASH Patients: What We Know so Far
par: Schulz M, et autres
Publié: (2020) -
Black students applying and admitted to medicine in the province of Quebec, Canada: what do we know so far?
par: Jean-Michel Leduc, et autres
Publié: (2021)